Bart Neyns
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 118
- CAR-T cell therapy research 88
- Colorectal Cancer Treatments and Studies 38
- Cutaneous Melanoma Detection and Management 36
- Immunology top 0.2%
- Immunotherapy and Immune Responses 75
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 65
- Cancer Research top 1%
- Pathology and Forensic Medicine top 0.5%
-
- Melanoma and MAPK Pathways 57
-
- Brain Metastases and Treatment 42
- Co-authors
- Sofie WilgenhofKris ThielemansEric Van CutsemAlain HendliszCarlo HeirmanJurgen CorthalsJean‐Jacques GrobMarc Peeters
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Clinical Oncology (70 papers)Annals of Oncology (32 papers)Melanoma Research (21 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Bart Neyns
297 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 9.8k
- Immunology 4.4k
- Genetics 1.7k
- Cancer Research 1.6k
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by Bart Neyns
This map shows the geographic impact of Bart Neyns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Neyns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Neyns more than expected).
Fields of papers citing papers by Bart Neyns
This network shows the impact of papers produced by Bart Neyns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Neyns. The network helps show where Bart Neyns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart Neyns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 31 | |
| 11 | Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab | 2019 | 1 |
| 12 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancerbreakdown → | 2018 | 1429 |
| 13 | 2016 | 240 | |
| 14 | 2014 | 33 | |
| 15 | 2010 | 341 | |
| 16 | CLINICAL OUTCOME OF PATIENTS TREATED WITH HEPATIC ARTERIAL INFUSION OF OXALIPLATIN AND L-FOLINIC ACID MODULATED 5-FLUOROURACIL FOR INOPERABLE COLORECTAL CANCER LIVER METASTASES, A SINGLE CENTER EXPERIENCE | 2010 | 1 |
| 17 | EFFECT OF DOSE ON EFFICACY AND SAFETY IN IPILIMUMAB-TREATED PATIENTS WITH ADVANCED MELANOMA - RESULTS FROM A PHASE II, RANDOMIZED, DOSE-RANGING STUDY | 2008 | 6 |
| 18 | 2008 | 8 | |
| 19 | Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial | 2006 | 2 |
| 20 | A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver | 2004 | 2 |
About Bart Neyns
Bart Neyns is a scholar working on Oncology, Genetics and Immunology, having authored 316 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (118 papers), CAR-T cell therapy research (88 papers), Immunotherapy and Immune Responses (75 papers), Glioma Diagnosis and Treatment (65 papers), Melanoma and MAPK Pathways (57 papers), Brain Metastases and Treatment (42 papers), Colorectal Cancer Treatments and Studies (38 papers) and Cutaneous Melanoma Detection and Management (36 papers). The work is most often cited by research in Oncology (9.8k citations), Immunology (4.4k citations) and Genetics (1.7k citations). Bart Neyns has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Sofie Wilgenhof, Kris Thielemans, Eric Van Cutsem, Alain Hendlisz, Carlo Heirman, Jurgen Corthals, Jean‐Jacques Grob, Marc Peeters, Yves Humblet and Joan Maurel. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, Cancers and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.